Gastric, or Gastroesophageal Junction Adenocarcinoma Clinical Trials

Gastric, or Gastroesophageal Junction Adenocarcinoma

Explore clinical trials studying Gastric, or Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Gastric, or Gastroesophageal Junction Adenocarcinoma trial results

Completed

Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma

NCT03777657

Conditions: Gastric, or Gastroesophageal Junction Adenocarcinoma
Locations: University of California Davis Health System Sacramento, California, United States

Southeastern Regional Medical Center Newnan, Georgia, United States

Ohio State University Hospital Columbus, Ohio, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View all 149 locations

View Trial Details